HEPION PHARMACEUTICALS, INC. Operating Lease Liability
HEPION PHARMACEUTICALS, INC. (HEPA) had Operating Lease Liability of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-12
- 2025-12-31: Operating Lease, Liability $0.00.
- 2025-09-30: Operating Lease, Liability $0.00.
- 2025-06-30: Operating Lease, Liability $0.00.
- 2025-03-31: Operating Lease, Liability $0.00.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-19 |
| 2024-09-30 | $117.95K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $154.09K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $175.27K 10-Q · filed 2024-05-21 |
| 2023-12-31 | $209.02K 10-K · filed 2024-04-16 |
| 2023-09-30 | $241.54K 10-Q · filed 2023-11-20 |
| 2022-12-31 | $53.61K 10-K · filed 2023-04-10 |
| 2022-09-30 | $105.58K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $176.86K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $247.34K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $316.99K 10-K · filed 2022-04-08 |
| 2021-09-30 | $384.42K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $452.87K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $511.52K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $575.58K 10-K · filed 2021-03-31 |
| 2020-09-30 | $633.77K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $692.86K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $745.48K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $807.45K 10-K · filed 2020-05-14 |
| 2019-09-30 | $651.94K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $692.92K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $733.37K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |